Catalyst Wire Dossier Catalyst Wire Dossier

Vernakalant Injection

vernakalant · Advanz Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vernakalant Injection, covering 2014-03-10 to 2014-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045) [Phase 3]

See pricing